Increasing Treatment Uptake for Chronic Hepatitis B in South America: A Comparative Analysis of Country‐Specific and WHO 2024 Guidelines
Journal of Viral Hepatitis · 2025-06 · 32 (6)
DOI: 10.1111/jvh.70035 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Viral Hepatitis, online erschienen am 26.05.2025. Verfasst von Manuel Mendizabal und 31 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Hígado y Trasplante Hepático, Hospital Universitario Austral, Pilar, Argentina. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Antiviral Agents, Practice Guidelines as Topic, Guideline Adherence. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
The 2024 WHO guidelines for chronic hepatitis B ( CHB ) aim to expand and simplify treatment eligibility. We aimed to estimate treatment eligibility and uptake according to country‐specific guidelines and evaluate treatment expansion based on the WHO guidelines. Treatment‐naïve CHB patients from Argentina, Brazil, Chile and Uruguay referred to evaluation between January 2010 and June 2024 were retrospectively included. Treatment candidacy was evaluated according to both country‐specific and WHO guidelines. A total of 719 patients with CHB , treatment naïve, were included (67.1% male; median age: 50.4 years; HBeAg ‐positive: 36.3%). The median HBV ‐ DNA level was 43,000 ( IQR 633–110,000,000) IU /mL, median ALT was 41 ( IQR 23–99) U/L, 47.0% had an APRI > 0.5 and 21.1% had cirrhosis. According to country‐specific guidelines, 56.9% (95% CI : 53.2–60.5) met the criteria for treatment. Antiviral treatment was initiated in 84.3% of eligible patients. The proportion of patients meeting treatment criteria under the WHO guidelines increased to 67.3% (95% CI : 63.8–70.6), resulting in a 10.4% (95% CI : 8.1–12.8) increase in treatment candidacy. Treatment expansion was significantly higher in women (15.2%; 95% CI : 10.2–20.1) than in men (8.1%; 95% CI : 5.4–10.7). According to WHO guidelines, a considerable proportion of CHB patients who do not meet country‐specific criteria are eligible for antiviral therapy. Implementing WHO criteria can enhance treatment rates and advance efforts toward CHB elimination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unidad de Hígado y Trasplante Hepático, Hospital Universitario Austral, Pilar, Argentina.
- Sección Hepatología, Hospital de Clínicas José de San Martín, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
- Inmunología, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina.
- Sección Hepatología, Departamento de Medicina, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno "CEMIC", Ciudad Autónoma de Buenos Aires, Argentina.
- Departamento de Gastroenterología, Pontificia Universidad Católica de Chile, Santiago, Chile.
- Sección de Gastroenterología, Departamento de Medicina, Hospital Clínico de la Universidad de Chile, Santiago, Chile.
ORCID-Profile: Manuel Mendizabal, Ezequiel Ridruejo
Zitieren
APA
Mendizabal, M., Sabate, C. D., González Ballerga, E., Gruz, F., Ridruejo, E., Soza, A., Poniachik, J., Vergara, G., Mainardi, V., Mezzano, G., Bessone, F., Anders, M., Pessoa, M. G., Cairo, F., Chiodi, D., Dirchwolf, M., Cheinquer, H., Susana, M., Rondeau, L., …, & Marciano, S. (2025). Increasing Treatment Uptake for Chronic Hepatitis B in South America: A Comparative Analysis of Country‐Specific and WHO 2024 Guidelines. Journal of Viral Hepatitis, 32(6). https://doi.org/10.1111/jvh.70035
Vancouver
Mendizabal M, Sabate CD, González Ballerga E, Gruz F, Ridruejo E, Soza A, et al. Increasing Treatment Uptake for Chronic Hepatitis B in South America: A Comparative Analysis of Country‐Specific and WHO 2024 Guidelines. Journal of Viral Hepatitis. 2025;32(6). doi:10.1111/jvh.70035
BibTeX
@article{Mendizabal2025,
author = {Mendizabal, Manuel and Sabate, Constanza D and González Ballerga, Esteban and Gruz, Fernando and Ridruejo, Ezequiel and Soza, Alejandro and Poniachik, Jaime and Vergara, Grace and Mainardi, Victoria and Mezzano, Gabriel and Bessone, Fernando and Anders, Margarita and Pessoa, Mario G and Cairo, Fernando and Chiodi, Daniela and Dirchwolf, Melisa and Cheinquer, Hugo and Susana, Melina and Rondeau, Luis and Rifrani, Gabriel and Aguirre, Herman and Hernandez, Nelia and Enrique, Carla and Navarro, Lucia and Labaronnie, Eugenia and Zitelli, Patricia M and de Araujo, Alexandre and Olivetti, Antonella and Simian, Daniela and Giunta, Diego and Silva, Marcelo and Marciano, Sebastián},
title = {Increasing Treatment Uptake for Chronic Hepatitis B in South America: A Comparative Analysis of Country‐Specific and WHO 2024 Guidelines},
journal = {Journal of Viral Hepatitis},
year = {2025},
volume = {32},
number = {6},
doi = {10.1111/jvh.70035}
}
EUVIMED